Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.

Abstract:

:A dose-response study in carcinogenesis was carried out with N-nitrosomorpholine in female F344 rats. The compound was administered in drinking water, which was supplied in controlled amounts of 20 ml per day per rat, 5 days a wk. At the two highest dose rates, 100 mg/liter and 40 mg/liter, treatment lasted 25 and 40 wk, respectively. At the other dose rates, which differed by a factor of 2.5, treatment lasted 50 or 100 wk. The average total dose received by each rat ranged from 250 mg to 0.7 mg. There were 100 animals per group at the lowest dose rates and 24 animals per group at the highest dose rates. Total doses of nitrosomorpholine above approximately 30 mg per rat caused a statistically significant decrease in survival, but at lower doses survival was similar to that of untreated controls. In nearly all of the treated groups there was a statistically significant increase in the incidence of benign or malignant hepatocellular neoplasms, with a highly significant dose-related trend. At the higher doses there was a significant incidence of hemangiosarcomas of the liver. Both hepatocellular carcinomas and hemangiosarcomas metastasized to the lungs and other organs. At the highest doses there was a significant incidence of neoplasms of the tongue and esophagus, which were rarely seen at the lower doses. The results suggest that even the lowest dose of nitrosomorpholine received by the rats, 0.7 mg or approximately 3 mg/kg body weight, was not a no-effect dose during the 2-yr lifetime of a rat. Probit analysis of the results indicate a dose estimated to cause tumors in 50% of the population of 25 mg nitrosomorpholine for liver neoplasms.

journal_name

Cancer Res

journal_title

Cancer research

authors

Lijinsky W,Kovatch RM,Riggs CW,Walters PT

subject

Has Abstract

pub_date

1988-04-15 00:00:00

pages

2089-95

issue

8

eissn

0008-5472

issn

1538-7445

journal_volume

48

pub_type

杂志文章
  • Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia.

    abstract::TEL-AML1 gene fusion derived by chromosomal translocation is a common acquired genetic lesion in pediatric cancer that is present in approximately 25% of B-cell precursor acute lymphoblastic leukemias, and recent evidence suggests that this recombination event may initiate leukemogenesis prenatally during fetal hemopo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wiemels JL,Greaves M

    更新日期:1999-08-15 00:00:00

  • Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.

    abstract::Overexpression of colony-stimulating factor-1 (CSF-1) and its receptor in breast cancer is correlated with poor prognosis. Based on the hypothesis that blockade of CSF-1 would be beneficial in breast cancer treatment, we developed a murinized, polyethylene glycol-linked antigen-binding fragment (Fab) against mouse (ho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3523

    authors: Paulus P,Stanley ER,Schäfer R,Abraham D,Aharinejad S

    更新日期:2006-04-15 00:00:00

  • Mutation in the nm23 gene is associated with metastasis in colorectal cancer.

    abstract::The human nm23 gene, a candidate metastatic suppressor gene, consists of two genes, nm23-H1 and nm23-H2. The potential mutation in the nm23-H1 gene was examined in colorectal cancer using a reverse transcription polymerase chain reaction amplification followed by DNA sequencing analysis. Genomic alterations in the nm2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wang L,Patel U,Ghosh L,Chen HC,Banerjee S

    更新日期:1993-02-15 00:00:00

  • Acidity generated by the tumor microenvironment drives local invasion.

    abstract::The pH of solid tumors is acidic due to increased fermentative metabolism and poor perfusion. It has been hypothesized that acid pH promotes local invasive growth and metastasis. The hypothesis that acid mediates invasion proposes that H(+) diffuses from the proximal tumor microenvironment into adjacent normal tissues...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2796

    authors: Estrella V,Chen T,Lloyd M,Wojtkowiak J,Cornnell HH,Ibrahim-Hashim A,Bailey K,Balagurunathan Y,Rothberg JM,Sloane BF,Johnson J,Gatenby RA,Gillies RJ

    更新日期:2013-03-01 00:00:00

  • Sequence-specific inhibition of DNA strand elongation by incorporation of 9-beta-D-arabinofuranosyladenine.

    abstract::9-beta-D-Arabinofuranosyladenine (ara-A) is an inhibitor of DNA replication with antitumor and antiviral activity. The molecular basis for this inhibitory effect has remained unclear. The present work has examined the effects of 9-beta-D-arabinofuranosyladenine-triphosphate on DNA polymerase-beta. These studies were p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ohno Y,Spriggs D,Matsukage A,Ohno T,Kufe D

    更新日期:1989-04-15 00:00:00

  • Growth of preneoplastic mammary epithelial cells in serum-free medium.

    abstract::The conditions for growing preneoplastic mammary epithelial cells in primary cell cultures with serum-free factor-defined medium were established in a series of experiments. The cells, grown in Dulbecco's modified Eagle's medium with 0.6 mM Ca2+, epidermal growth factor, transferrin, insulin, and Na2SeO3, were fibrobl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Medina D,Oborn CJ

    更新日期:1980-11-01 00:00:00

  • CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics.

    abstract::We recently identified the immunoglobulin-CAM CD155/PVR (the poliovirus receptor) as a regulator of cancer invasiveness and glioma migration, but the mechanism through which CD155/PVR controls these processes is unknown. Here, we show that expression of CD155/PVR in rat glioma cells that normally lack this protein enh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1890

    authors: Sloan KE,Stewart JK,Treloar AF,Matthews RT,Jay DG

    更新日期:2005-12-01 00:00:00

  • PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.

    abstract::Glioblastoma is the most aggressive primary brain tumor and responds poorly to currently available therapies. Transcriptomic characterization of glioblastoma has identified distinct molecular subtypes of glioblastoma. Gain-of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2157

    authors: Rahme GJ,Zhang Z,Young AL,Cheng C,Bivona EJ,Fiering SN,Hitoshi Y,Israel MA

    更新日期:2016-05-15 00:00:00

  • Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.

    abstract::Mucin 1 (MUC1), a bound mucin glycoprotein, is overexpressed and aberrantly glycosylated in >80% of human ductal pancreatic carcinoma. Evidence suggests that MUC1 can be used as a tumor marker and is a potential target for immunotherapy of pancreatic cancer. However, vaccination with MUC1 peptides fails to stimulate t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-4313

    authors: Deguchi T,Tanemura M,Miyoshi E,Nagano H,Machida T,Ohmura Y,Kobayashi S,Marubashi S,Eguchi H,Takeda Y,Ito T,Mori M,Doki Y,Sawa Y

    更新日期:2010-07-01 00:00:00

  • Mitochondrial and microsomal phospholipids of Morris hepatoma 7777.

    abstract::The phospholipids of both mitochondrial and microsomal membranes from normal liver, host liver, and Morris hepatoma 7777 were isolated, separated, and quantitated. The total as well as the individual fatty acid concentrations and compositions were determined. The total phosphlipids isolated from tumor mitochondria wer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reitz RC,Thompson JA,Morris HP

    更新日期:1977-02-01 00:00:00

  • Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies.

    abstract::Gastrointestinal malignancy may spread to peritoneal surfaces in the absence of lymphatic or hematogenous metastases. To treat peritoneal carcinomatosis, a uniformly lethal disease process, extensive cytoreductive surgery and i.p. chemotherapy were combined. Early postoperative i.p. chemotherapy was instilled in the f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sugarbaker PH,Graves T,DeBruijn EA,Cunliffe WJ,Mullins RE,Hull WE,Oliff L,Schlag P

    更新日期:1990-09-15 00:00:00

  • Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.

    abstract::Nerve growth factor-like substance(s) were identified in both conditioned media of a human prostatic tumor epithelial cell line (TSU-pr1) and a human prostatic stromal cell line (HPS) by Western blot analysis and bioassay of neurite outgrowth of PC12 cells. Nerve growth factor-beta (NGF) immunofluorescence was also lo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Djakiew D,Delsite R,Pflug B,Wrathall J,Lynch JH,Onoda M

    更新日期:1991-06-15 00:00:00

  • Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

    abstract::Recent preclinical studies have shown that frequent administration in vivo of low doses of chemotherapeutic drugs ("metronomic" dosing) can affect tumor endothelium and inhibit tumor angiogenesis, reducing significant side effects (e.g., myelosuppression) involving other tissues, even after chronic treatment. This sug...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bocci G,Nicolaou KC,Kerbel RS

    更新日期:2002-12-01 00:00:00

  • MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles.

    abstract::MCT-1 is an oncogene that was initially identified in a human T cell lymphoma and has been shown to induce cell proliferation as well as activate survival-related pathways. MCT-1 contains the PUA domain, a recently described RNA-binding domain that is found in several tRNA and rRNA modification enzymes. Here, we estab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1999

    authors: Reinert LS,Shi B,Nandi S,Mazan-Mamczarz K,Vitolo M,Bachman KE,He H,Gartenhaus RB

    更新日期:2006-09-15 00:00:00

  • In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.

    abstract::The outcome of patients with advanced stage rhabdomyosarcoma is extremely poor, with a disease-free survival of less than 20% at 3 years. Autologous bone marrow transplantation for patients with Clinical Group IV rhabdomyosarcoma may be an effective therapy. The bone marrow involvement diagnosed by light microscopy is...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ozkaynak MF,Nolta J,Parkman R

    更新日期:1990-03-01 00:00:00

  • Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration.

    abstract::Dysregulation of Wnt/β-catenin signaling is frequently observed in human gastric cancer. Elucidation of the tumor immune microenvironment is essential for understanding tumorigenesis and for the development of immunotherapeutic strategies. However, it remains unclear how β-catenin signaling regulates the tumor immune ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3074

    authors: Ji L,Qian W,Gui L,Ji Z,Yin P,Lin GN,Wang Y,Ma B,Gao WQ

    更新日期:2020-05-15 00:00:00

  • Shark cartilage, cancer and the growing threat of pseudoscience.

    abstract::The promotion of crude shark cartilage extracts as a cure for cancer has contributed to at least two significant negative outcomes: a dramatic decline in shark populations and a diversion of patients from effective cancer treatments. An alleged lack of cancer in sharks constitutes a key justification for its use. Here...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2260

    authors: Ostrander GK,Cheng KC,Wolf JC,Wolfe MJ

    更新日期:2004-12-01 00:00:00

  • Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.

    abstract::Many epithelial tumors show deletion of the short arm of chromosome 8 that is related to aggressive disease or adverse prognosis. In undissected samples of urothelial cell carcinoma of the bladder, at least two regions of loss of heterozygosity (LOH) were identified previously within a small region of 8p11-p12. LOH an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Adams J,Williams SV,Aveyard JS,Knowles MA

    更新日期:2005-01-01 00:00:00

  • In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.

    abstract::Antitumor immunity requires (a) extravasation of lymphocytes from the blood stream to interstitium, (b) locomotion through extracellular matrix to the site of the tumor, (c) effector cell recognition of the tumor target with cell/cell contact and binding of adhesion receptors, (d) T-cell receptor binding to histocompa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Applegate KG,Balch CM,Pellis NR

    更新日期:1990-11-15 00:00:00

  • In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.

    abstract::The biodistribution characteristics of a humanized anti-Lewis(y) antibody (hu3S193) radiolabeled to three radioisotopes, 125I, 111In, and 90Y, were examined in a BALB/c nude mouse xenograft model of breast cancer. The immunoreactivity of both 125I- and 111In-bound hu3S193 exceeded 50% and was 20% for 90Y. In vivo, lab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Clarke K,Lee FT,Brechbiel MW,Smyth FE,Old LJ,Scott AM

    更新日期:2000-09-01 00:00:00

  • PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.

    abstract::We show here that PRL-3 protein is expressed in fetal heart, developing blood vessels, and pre-erythrocytes but not in their mature counterparts. These observations imply that PRL-3 may be involved in the early development of the circulatory system. Because PRL-3 mRNA had been reported to be consistently elevated in m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0726

    authors: Guo K,Li J,Wang H,Osato M,Tang JP,Quah SY,Gan BQ,Zeng Q

    更新日期:2006-10-01 00:00:00

  • Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.

    abstract::ADAMs (a disintegrin and metalloproteinase) have important roles in development and diseases such as cancer. Previously, an ADAM15 splice variant (ADAM15B), which contains an inserted cytoplasmic Src-binding site, was linked to clinical aggressiveness in breast cancer, yet little was known about how this splice varian...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4766

    authors: Maretzky T,Le Gall SM,Worpenberg-Pietruk S,Eder J,Overall CM,Huang XY,Poghosyan Z,Edwards DR,Blobel CP

    更新日期:2009-06-01 00:00:00

  • Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.

    abstract::The SK3 channel, a potassium channel, was recently shown to control cancer cell migration, a critical step in metastasis outgrowth. Here, we report that expression of the SK3 channel was markedly associated with bone metastasis. The SK3 channel was shown to control constitutive Ca(2+) entry and cancer cell migration t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-4572

    authors: Chantôme A,Potier-Cartereau M,Clarysse L,Fromont G,Marionneau-Lambot S,Guéguinou M,Pagès JC,Collin C,Oullier T,Girault A,Arbion F,Haelters JP,Jaffrès PA,Pinault M,Besson P,Joulin V,Bougnoux P,Vandier C

    更新日期:2013-08-01 00:00:00

  • Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.

    abstract::This study describes a novel approach to the treatment of brain tumors with the combination of recombinant L-methionine-alpha-deamino-gamma-lyase and chemotherapeutic regimens that are currently used against such tumors. The growth of Daoy, SWB77, and D-54 xenografts in athymic mice was arrested after the depletion of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kokkinakis DM,Hoffman RM,Frenkel EP,Wick JB,Han Q,Xu M,Tan Y,Schold SC

    更新日期:2001-05-15 00:00:00

  • p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

    abstract::Tumor-associated macrophages (TAM) are a major inflammatory infiltrate in tumors and a major component of the protumor function of inflammation. TAM in established tumors generally have an M2 phenotype with defective production of interleukin-12 (IL-12) and high IL-10. Here, we report that defective responsiveness of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1867

    authors: Saccani A,Schioppa T,Porta C,Biswas SK,Nebuloni M,Vago L,Bottazzi B,Colombo MP,Mantovani A,Sica A

    更新日期:2006-12-01 00:00:00

  • dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae.

    abstract::The thymidylate synthase reaction remains an important target for widely used anticancer agents; however, the clinical utility of these drugs is limited by the occurrence of cellular resistance. Despite the considerable amount of information available regarding mechanisms of drug action, the relative significance of d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tinkelenberg BA,Hansbury MJ,Ladner RD

    更新日期:2002-09-01 00:00:00

  • Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.

    abstract::Monoclonal antibody B72.3, reactive with a high-molecular-weight glycoprotein tumor-associated antigen (designated TAG-72), has been previously shown to be reactive with formalin-fixed paraffin-embedded tissue sections of adenocarcinomas of the ovary, colon, and breast and not a variety of normal adult tissues. It has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Johnston WW,Szpak CA,Thor A,Schlom J

    更新日期:1986-12-01 00:00:00

  • Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein.

    abstract::The pharmacokinetics of UCN-01 after administration as a 72- or 3-h infusion to cancer patients in initial Phase I trials displayed distinctive features that could not have been predicted from preclinical data. The distribution volumes (0.0796-0.158 liters/kg) and the systemic clearance (0.0407-0.252 ml/h/kg) were ext...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Fuse E,Tanii H,Kurata N,Kobayashi H,Shimada Y,Tamura T,Sasaki Y,Tanigawara Y,Lush RD,Headlee D,Figg WD,Arbuck SG,Senderowicz AM,Sausville EA,Akinaga S,Kuwabara T,Kobayashi S

    更新日期:1998-08-01 00:00:00

  • A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

    abstract::Emerging evidence supporting the activation of the Akt-mammalian target of rapamycin (mTOR) signaling network in head and neck squamous cell carcinoma (HNSCC) progression has provided the rationale for exploring the therapeutic potential of inhibiting this pathway for HNSCC treatment. Indeed, rapamycin, a clinically r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1756

    authors: Amornphimoltham P,Patel V,Leelahavanichkul K,Abraham RT,Gutkind JS

    更新日期:2008-02-15 00:00:00

  • APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.

    abstract::The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like APOBEC3A and APOBEC3B have emerged as key mutation drivers in cancer. Here, we show that APOBEC3A and APOBEC3B activities impose a unique type of replication stress by inducing abasic sites at replication forks. In contrast to cells under other types ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3389

    authors: Buisson R,Lawrence MS,Benes CH,Zou L

    更新日期:2017-09-01 00:00:00